150,79 €
Directory of Approved Biopharmaceutical Products
Directory of Approved Biopharmaceutical Products
  • Išparduota
Directory of Approved Biopharmaceutical Products
Directory of Approved Biopharmaceutical Products
El. knyga:
150,79 €
Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially a

Directory of Approved Biopharmaceutical Products (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

(2.00 Goodreads įvertinimas)
Įvertink ir tu! Visi atsiliepimai

Formatai:

150,79 € El. knyga

Aprašymas

Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially a

150,79 €
Prisijunkite ir už šią prekę
gausite 1,51 Knygų Eurų! ?

Elektroninė knyga:
Atsiuntimas po užsakymo akimirksniu! Skirta skaitymui tik kompiuteryje, planšetėje ar kitame elektroniniame įrenginyje.

Kaip skaityti el. knygas ACSM formatu?

Mažiausia kaina per 30 dienų: 150,79 €

Mažiausia kaina užfiksuota: Kaina nesikeitė


Biopharmaceuticals, the term for genetically engineered therapeutic proteins, monoclonal antibodies, and nucleic acid-based products, have become an increasing part of the pharmaceutical armament. While this category of drugs accounts for approximately 25% of all new drugs coming to market, very few references exist that review these commercially a

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)
Knygos.lt komentarų taisyklės